Lev Pharmaceuticals Inc. (LEVP.OB) Granted Authorization to File for European Distribution Rights for Lead Drug Candidate
Lev Pharmaceuticals Inc. (OTCBB: LEVP) develops and commercializes therapeutic products for inflammatory diseases. Its lead product candidate, Cinryze (C1 inhibitor),…